Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Presentation Interventional Complications 2022

Orbital Atherectomy Complications: Avoiding Perforations and the More Arcane

Presenter: Allen Jeremias

July 16, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Daily News

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Shelley Wood

February 19, 2020

Presentation JIM 2020

Caught between a rock and a hard place: Lithotripsy & Orbital Atherectomy

Presenter: Carlo Di Mario

February 13, 2020

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

Advertisement

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Top Coronary Artery Disease News in 2024

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Orbital Atherectomy Complications: Avoiding Perforations and the More Arcane

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Elective Revascularization, Better Long-term Survival: Meta-analysis

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Caught between a rock and a hard place: Lithotripsy & Orbital Atherectomy

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content